Skyline Medical, Inc. Compliant with All Nasdaq Listing Criteria
February 17 2017 - 7:30AM
Skyline Medical, Inc. (NASDAQ:SKLN) today announced that it has
received formal notice from The NASDAQ Stock Market LLC (“Nasdaq”)
indicating that the Company has evidenced full compliance with all
requirements for continued listing on The Nasdaq Capital Market,
and that the Company’s common stock will continue to be listed on
Nasdaq. The previously disclosed listing matter has now been
closed.
About the STREAMWAY
SystemSkyline's revolutionary, FDA-cleared STREAMWAY
system is the first true direct-to-drain fluid disposal system
designed specifically for medical applications, such as radiology,
endoscopy, urology and cystoscopy procedures. It connects directly
to a facility's plumbing system to automate the collection,
measurement and disposal of waste fluids. As of September 30,
2016, Skyline Medical customers have installed 96 STREAMWAY systems
in 50 facilities across 19 states.
The STREAMWAY minimizes human intervention for
better safety and improves compliance with Occupational Safety and
Health Administration (OSHA) and other regulatory agency safety
guidelines. It also provides unlimited capacity for increased
efficiency in the operating room, which leads to greater
profitability. Furthermore, the STREAMWAY eliminates canisters to
reduce overhead costs and provides greater environmental
stewardship by helping to eliminate the approximately 50 million
potentially disease-infected canisters that go into landfills
annually in the U.S. For a demonstration please visit
www.skylinemedical.com or call 855-785-8855.
About Skyline MedicalSkyline
Medical produces a fully automated, patented, FDA-cleared waste
fluid disposal system that virtually eliminates staff exposure to
blood, irrigation fluid and other potentially infectious fluids
found in the healthcare environment. Antiquated manual fluid
handling methods that require hand carrying and emptying filled
fluid canisters present an exposure risk and potential liability.
Skyline Medical's STREAMWAY System fully automates the collection,
measurement and disposal of waste fluids and is designed to: 1)
reduce overhead costs to hospitals and surgical centers; 2) improve
compliance with OSHA and other regulatory agency safety guidelines;
3) improve efficiency in the operating room, and radiology and
endoscopy departments, thereby leading to greater profitability;
and 4) provide greater environmental stewardship by helping to
eliminate the approximately 50 million potentially disease-infected
canisters that go into landfills each year in the U.S. For
additional information, please visit www.skylinemedical.com.
Forward-looking
StatementsCertain of the matters discussed in this
announcement contain forward-looking statements that involve
material risks to and uncertainties in the Company's business that
may cause actual results to differ materially from those
anticipated by the statements made herein. Such risks and
uncertainties include, among other things, current negative
operating cash flows and a need for additional funding to finance
our operating plan; the terms of any further financing, which may
be highly dilutive and may include onerous terms; unexpected costs
and operating deficits, and lower than expected sales and revenues;
uncertain willingness and ability of customers to adopt new
technologies and other factors that may affect further market
acceptance, if our product is not accepted by our potential
customers, it is unlikely that we will ever become profitable,
adverse economic conditions; adverse results of any legal
proceedings; the volatility of our operating results and financial
condition; inability to attract or retain qualified senior
management personnel, including sales and marketing personnel; our
ability to establish and maintain the proprietary nature of our
technology through the patent process, as well as our ability to
possibly license from others patents and patent applications
necessary to develop products; the Company's ability to implement
its long range business plan for various applications of its
technology, including the possibility that the development of
applicable technologies by GLG Pharma, LLC will be delayed, will
not occur or will not receive applicable regulatory approvals on a
timely basis; the Company’s ability to consummate its joint venture
with Electronic On-Ramp, Inc.; the Company's ability to enter into
agreements with any necessary marketing and/or distribution
partners; the impact of competition, the obtaining and maintenance
of any necessary regulatory clearances applicable to applications
of the Company's technology; and management of growth and other
risks and uncertainties that may be detailed from time to time in
the Company's reports filed with the Securities and Exchange
Commission, which are available for review at www.sec.gov.
This is not a solicitation to buy or sell securities and does not
purport to be an analysis of the Company's financial position. See
the Company's most recent Annual Report on Form 10-K, and
subsequent reports and other filings at www.sec.gov.
Contact:
Investors
LHA
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
MoneyInfo, LLC
Charles Moskowitz
(781) 826-8882
cam@moneyinfo-llc.com
Precision Therapeutics Inc. (NASDAQ:AIPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Precision Therapeutics Inc. (NASDAQ:AIPT)
Historical Stock Chart
From Apr 2023 to Apr 2024